Nucleotide analogs
US-9801884-B2 · Oct 31, 2017 · US
Acyclic nucleoside phosphonate diesters
US10076533B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10076533-B2 |
| Application number | US-201715809400-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 10, 2017 |
| Priority date | Mar 15, 2013 |
| Publication date | Sep 18, 2018 |
| Grant date | Sep 18, 2018 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present disclosure relates, inter alia, to compositions and methods for treating viral diseases and cancer. There are disclosed lipophilic antiviral and anticancer acyclic nucleoside phosphonate diesters, preparation thereof, and methods of using the compounds to treat viral diseases and cancer.
First claim
Opening claim text (preview).
What is claimed is: 1. A method of treating cervical intraepithelial neoplasia, anal intraepithelial neoplasia, or vulvar intraepithelial neoplasia in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of a compound of formula: or a pharmaceutically acceptable salt thereof, optionally in a pharmaceutically acceptable carrier. 2. The method of claim 1 , wherein the subject is a human. 3. The method of claim 1 , wherein the compound is topically administered as a topical formulation. 4. The method of claim 3 , wherein the topical formulation is a cream. 5. The method of claim 3 , wherein the topical formulation is a gel. 6. The method of claim 1 for treating cervical intraepithelial neoplasia. 7. The method of claim 6 , wherein the subject is a human. 8. The method of claim 6 , wherein the compound is topically administered as a topical formulation. 9. The method of claim 8 , wherein the topical formulation is a cream. 10. The method of claim 8 , wherein the topical formulation is a gel. 11. The method of claim 1 for treating anal intraepithelial neoplasia. 12. The method of claim 11 , wherein the subject is a human. 13. The method of claim 11 , wherein the compound is topically administered as a topical formulation. 14. The method of claim 13 , wherein the topical formulation is a cream. 15. The method of claim 13 , wherein the topical formulation is a gel. 16. The method of claim 1 for treating vulvar intraepithelial neoplasia. 17. The method of claim 16 , wherein the subject is a human. 18. The method of claim 16 , wherein the compound is topically administered as a topical formulation. 19. The method of claim 18 , wherein the topical formulation is a cream. 20. The method of claim 18 , wherein the topical formulation is a gel. 21. The method of claim 1 , wherein the cervical intraepithelial neoplasia, the anal intraepithelial neoplasia, or the vulvar intraepithelial neoplasia is caused by a human papilloma virus.
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10076533B2 cover?
- The present disclosure relates, inter alia, to compositions and methods for treating viral diseases and cancer. There are disclosed lipophilic antiviral and anticancer acyclic nucleoside phosphonate diesters, preparation thereof, and methods of using the compounds to treat viral diseases and cancer.
- Who is the assignee on this patent?
- Univ California
- What technology area does this patent fall under?
- Primary CPC classification C07F9/65616. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Sep 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).